Dr. Reddy's gets EIR for API manufacturing facility in New York

22 Jul 2025 Evaluate

Dr. Reddy's Laboratories has received the Establishment Inspection Report (EIR) from United States Food & Drug Administration (USFDA) for its API facility in Middleburgh, New York. The USFDA has classified the inspection outcome as Voluntary Action Indicated (VAI) and concluded that the inspection is officially closed under 21 CFR 20.64(d)(3). Earlier on May 12, 2025, USFDA had conducted GMP inspection at company’s API Middleburgh facility in New York.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1275.05 -1.95 (-0.15%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×